Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Xilio Development Inc
XLOCurrent price
1 USD
-0.073 USD (-6.84%)
Last closed
1.08 USD
Company
www.xiliotx.com
ISIN
US98422T1007
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
43 517 372 USD
Yield for 12 month
-23.85 %
1Y
3Y
5Y
10Y
15Y
XLO
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company's checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which comprises XTX202, a tumor-activated beta-gamma biased IL-2, currently under Phase 2 clinal trials; and XTX301, an investigational tumor-activated, engineered IL-12 molecule, currently under Phase 1 studies. The company was founded in 2016 and is headquartered in Waltham, Massachusetts. Address: 828 Winter Street, Waltham, MA, United States, 02451
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
4.5 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
+2 263 000 USD
Last Quarter
+2 357 000 USD
Current Year
-1 900 000 USD
Last Year
-1 847 000 USD
Current Quarter
+2 263 000 USD
Last Quarter
+1 912 000 USD
Key Figures XLO
1 year
3 years
5 years
10 years
EBITDA
-64 907 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-45.76 %
PEG Ratio
–
Return On Equity TTM
-130.03 %
Wall Street Target Price
4.5 USD
Revenue TTM
2 357 000 USD
Book Value
1.33 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-56 774 000 USD
Earnings per share
-1.98 USD
Diluted Eps TTM
-1.98 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics XLO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History XLO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation XLO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
18.463
Enterprise Value EBITDA
-0.1098
Price Book MRQ
1.3023
Financials XLO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators XLO
For 52 weeks
0.49 USD
1.63 USD
50 Day MA
0.88 USD
Shares Short Prior Month
140 090
200 Day MA
0.92 USD
Short Ratio
0.76
Shares Short
104 746
Short Percent
0.29 %
BeatStart